Clinical Trial Update: A Phase III Clinical Study on the Efficacy and Safety of HRS-1780 in the Treatment of Patients With Chronic Kidney Disease [Phase 3]

View source ↗

Summary

A Phase III clinical study evaluating the efficacy and safety of HRS-1780 for chronic kidney disease is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Drugs mentioned

• HRS-1780

Snippet

Sponsor: Shandong Suncadia Medicine Co., Ltd. | Conditions: Chronic Kidney Disease | Phase 3 | Status: RECRUITING